Search

Gel-sol transition-based biosensors are a promising and popular alternative for portable, cost-effective, and user-friendly point-of-care testing (POCT). However, the improvement of sensitivity and practicability is highly demanded. In this work, a Fe-NC single-atom catalyst (SAC) is successfully synthesized and used as a signal amplification element for highly sensitive gel-sol transition-based biosensing. The Fe-NC SAC owns excellent peroxidase-like activity of 188 U/mg due to its definite atomically active centers and maximum atomic utilization of active metal atoms. As a proof-of-concept, the Fe-NC SAC is uniformly encapsulated in gelatin hydrogel to obtain a hydrogel sensor that allows colorimetric detection of trypsin based on gel-sol transition. The gelatin hydrogel network collapses derived from the hydrolysis by trypsin, and thereby the released Fe-NC SAC leads to the colorimetric sensing process. The designed hydrogel sensor offers a low detection limit of 1 ng/mL with a range from 1 to 100 ng/mL toward trypsin detection, exhibiting excellent selectivity and sensitivity, and well-performed practical detection in human serum. This work offers a successful paradigm for designing a promising SACs-related detection strategy and paves a new way to develop high-performance gel-sol transition-based sensors and various POCT applications., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)

Alzheimer's disease (AD), one of the leading senile disorders in the world, causes severe memory loss and cognitive impairment. To date, there is no clear cure for AD. However, early diagnosis and monitoring can help mitigate the effects of this disease. In this study, we reported a platform for diagnosing early-stage AD using microRNAs (miRNAs) in the blood as biomarkers. First, we selected an appropriate target miRNA (miR-574-5p) using AD model mice (4-month-old 5XFAD mice) and developed a hydrogel-based sensor that enabled high-sensitivity detection of the target miRNA. This hydrogel contained catalytic hairpin assembly (CHA) reaction-based probes, leading to fluorescence signal amplification without enzymes and temperature changes, at room temperature. This sensor exhibited high sensitivity and selectivity, as evidenced by its picomolar-level detection limit (limit of detection: 1.29 pM). Additionally, this sensor was evaluated using the plasma of AD patients and non-AD control to validate its clinical applicability. Finally, to use this sensor as a point-of-care-testing (POCT) diagnostic system, a portable fluorometer was developed and verified for feasibility of application., (Copyright © 2022. Published by Elsevier B.V.)

The eye is an extension of the central nervous system (CNS) and contains aqueous humor (AH), which is a fluid rich in biomolecules secreted from intraocular tissues; thus, this organ allows for non-invasive visualization of early changes in CNS disorders. There is a growing interest in developing implantable devices, such as intraocular-lens (IOL), for specific medical uses, including intraocular monitoring. We describe a novel IOL-sensing system for detecting AH biomarkers via biocompatible enzyme-activatable fluorogenic hydrogel sensors. Matrix-metalloproteinase-9, a biomarker of degenerative CNS and eye disorders, was selected as a target. A peptide-probe-incorporated fluorogenic IOL (FIOL) was developed using diacrylamide-group-modified poly(ethyleneglycol) (PEGDAAm) biocompatible hydrogels, adjusting the hydrogel mesh size to allow selective penetration of the target while blocking non-targets, using label-free detection with semi-permanently implantable sensors, and demonstrating the clinical feasibility of FIOL through in vivo testing. This novel FIOL-based sensing system represents a promising approach for liquid biopsy of intraocular fluids., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier B.V. All rights reserved.)